OBJECTIVE: To investigate the suppressive effect of a newly synthesized compound, 2-amino-3-cyano-5-(2-fluorophenyl)-4-methylpyrrole (NS-8), on micturition, and its mode and sites of action in rats. MATERIALS AND METHODS: Female rats were anaesthetized with urethane, and isovolumetric bladder contractions and cystometrograms recorded. The pelvic afferent discharges from the bladder were also monitored. RESULTS: In the cystometric study, NS-8 increased the bladder capacity without affecting the maximum bladder contraction pressure, an effect unlike that of currently used anticholinergic drugs for the overactive bladder, which commonly decrease the maximum bladder contraction pressure. Intravesical and intravenous injection of NS-8 inhibited isovolumetric bladder contractions in a dose-dependent manner without affecting their amplitude, whereas intracerebroventricular injection with NS-8 had no such effect. During the urine storage phase of the cystometrogram, NS-8 decreased the discharge rate of the afferent pelvic nerve from the bladder, in association with a decrease in the increase in intravesical pressure. CONCLUSION: NS-8 suppressed the micturition reflex by decreasing afferent pelvic nerve activity. Activation of calcium-sensitive potassium channel of the bladder may be responsible for such an effect. This agent has the potential to treat patients with urinary frequency and incontinence.
OBJECTIVE: To investigate the suppressive effect of a newly synthesized compound, 2-amino-3-cyano-5-(2-fluorophenyl)-4-methylpyrrole (NS-8), on micturition, and its mode and sites of action in rats. MATERIALS AND METHODS: Female rats were anaesthetized with urethane, and isovolumetric bladder contractions and cystometrograms recorded. The pelvic afferent discharges from the bladder were also monitored. RESULTS: In the cystometric study, NS-8 increased the bladder capacity without affecting the maximum bladder contraction pressure, an effect unlike that of currently used anticholinergic drugs for the overactive bladder, which commonly decrease the maximum bladder contraction pressure. Intravesical and intravenous injection of NS-8 inhibited isovolumetric bladder contractions in a dose-dependent manner without affecting their amplitude, whereas intracerebroventricular injection with NS-8 had no such effect. During the urine storage phase of the cystometrogram, NS-8 decreased the discharge rate of the afferent pelvic nerve from the bladder, in association with a decrease in the increase in intravesical pressure. CONCLUSION:NS-8 suppressed the micturition reflex by decreasing afferent pelvic nerve activity. Activation of calcium-sensitive potassium channel of the bladder may be responsible for such an effect. This agent has the potential to treat patients with urinary frequency and incontinence.
Authors: John Malysz; Steven A Buckner; Anthony V Daza; Ivan Milicic; Arturo Perez-Medrano; Murali Gopalakrishnan Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2004-04-17 Impact factor: 3.000
Authors: R J Large; A Kshatri; T I Webb; S Roy; A Akande; E Bradley; G P Sergeant; K D Thornbury; N G McHale; M A Hollywood Journal: Br J Pharmacol Date: 2015-03-26 Impact factor: 8.739
Authors: Bernhard Nausch; Frederik Rode; Susanne Jørgensen; Antonio Nardi; Mads P G Korsgaard; Charlotte Hougaard; Adrian D Bonev; William D Brown; Tino Dyhring; Dorte Strøbæk; Søren-Peter Olesen; Palle Christophersen; Morten Grunnet; Mark T Nelson; Lars C B Rønn Journal: J Pharmacol Exp Ther Date: 2014-06-20 Impact factor: 4.030
Authors: K S Thorneloe; A M Knorn; P E Doetsch; E S R Lashinger; A X Liu; C T Bond; J P Adelman; M T Nelson Journal: Am J Physiol Regul Integr Comp Physiol Date: 2008-03-19 Impact factor: 3.619